
4Dcell is a biotechnology company specializing in advanced 2D and 3D in vitro cell culture technologies designed to accelerate drug discovery and reduce animal testing. Their proprietary platforms, including SmartHeart and SmartContractility, enable precise modeling of cardiac and other tissues with high reproducibility and ease of use. The company integrates material sciences, physics, and AI-driven imaging analysis to deliver physiologically relevant models for drug efficacy, cardiotoxicity, and fundamental research. Their products support scalable, ethical, and predictive preclinical studies, positioning 4Dcell as a leader in organoid and tissue engineering solutions for pharmaceutical and biomedical research markets.

4Dcell is a biotechnology company specializing in advanced 2D and 3D in vitro cell culture technologies designed to accelerate drug discovery and reduce animal testing. Their proprietary platforms, including SmartHeart and SmartContractility, enable precise modeling of cardiac and other tissues with high reproducibility and ease of use. The company integrates material sciences, physics, and AI-driven imaging analysis to deliver physiologically relevant models for drug efficacy, cardiotoxicity, and fundamental research. Their products support scalable, ethical, and predictive preclinical studies, positioning 4Dcell as a leader in organoid and tissue engineering solutions for pharmaceutical and biomedical research markets.